Transgene Biotek share news, announcements and annual reports
BSE: 526139Healthcare ServicesSmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹2.33.
2 Nov: open ₹2.38, high ₹2.57, low ₹2.29
- Under BSE's graded surveillance, stage 0, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹19 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.22
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 21,872
Transgene Biotek share news and announcements
487 announcements, routine notices left out, newest first. Page 2 of 10.
Sep 2025
1 Sep · Subject: Intimation About The Initiation Of Insolvency Process. This Is To Inform About The Receipt Of Intimation Today From M/S Babaji Nethralayya Private Limited Initiating An Action Under Section 7 Of The Insolvency And Bankruptcy Code, 2016, Read With Rule 4 Of The Insolvency And Bankruptcy Board Of India (Application To Adjudicating Authority) Rules, 2016 For Corporate Insolvency Resolution Process.
Aug 2025
7 Aug · Results
Jul 2025
30 Jul · Board meeting
Meeting on 7 Aug 2025: quarterly results25 Jul · Compliance-57 (5) : intimation after the end of quarter
25 Jul · Business
May 2025
22 May · Results
7 May · Board meeting
Apr 2025
28 Apr · Board meeting
Meeting on 7 May 2025: audited results26 Apr · Compliance-57 (5) : intimation after the end of quarter
24 Apr · We Are Enclosing Hereto The Compliance Certificate As Per Clause 40(9) In The Prescribed Format For The Quarter Ended 31St March, 2025
19 Apr · Business
19 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Feb 2025
14 Feb · Results
Jan 2025
24 Jan · Results
20 Jan · Business
17 Jan · Board meeting
Meeting on 24 Jan 2025: quarterly results13 Jan · Legal
Dec 2024
31 Dec · Management
5 Dec · Meeting
Nov 2024
13 Nov · Results
12 Nov · Board meeting
4 Nov · Board meeting
Meeting on 12 Nov 2024: quarterly results and annual general meeting
Oct 2024
23 Oct · Receipt Of Legal Notice From BIRAC
18 Oct · Business
12 Oct · Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 30Th September 2024
12 Oct · Compliance Certificate
Aug 2024
10 Aug · Results
10 Aug · Board meeting
Jul 2024
21 Jul · Compliance-57 (5) : intimation after the end of quarter
21 Jul · Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 30Th June 2024.
19 Jul · Board meeting
Meeting on 10 Aug 2024: quarterly results
Jun 2024
28 Jun · Board meeting
13 Jun · Legal
Exchange has sought clarification from Transgene Biotek Ltd on June 12, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
May 2024
30 May · Board meeting